ALVO
Alvotech
NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.30
-6.25% today
Updated 2026-04-29
Market cap
$1.03B
P/E ratio
33.00
P/S ratio
1.75x
EPS (TTM)
$0.10
Dividend yield
—
52W range
$3 – $12
Volume
0.6M
Alvotech (ALVO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | — | $474.42M | $597.98M | $828.44M | $950.09M | $1.22B |
| Cash & equivalents | — | $31.69M | $17.56M | $66.43M | $11.16M | $51.43M |
| Current assets | — | $86.16M | $119.82M | $230.74M | $194.84M | $455.02M |
| Total liabilities | — | $1.34B | $733.59M | $1.39B | $1.88B | $1.63B |
| Current liabilities | — | $50.98M | $111.84M | $167.29M | $260.95M | $193.40M |
| Long-term debt | — | $565.40M | $398.14M | $744.65M | $922.13M | $1.04B |
| Shareholder equity | — | $-867.24M | $-135.61M | $-564.42M | $-932.49M | $-412.77M |
| Retained earnings | — | $-1.04B | $-1.14B | $-1.65B | $-2.21B | $-2.44B |
| Accounts receivable | — | $33.12M | $53.88M | $71.39M | $87.22M | $251.72M |
| Inventory | — | $9.65M | $39.06M | $71.47M | $74.43M | $127.89M |
| Goodwill | — | $13.43M | $12.37M | $11.64M | $12.06M | $11.33M |